<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>input-fr</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel ">Ordonnance du DEFR <br>sur le stockage obligatoire de médicaments</h1>
<p class="man-template-datum-aend ">Modification du 24 novembre 2023</p>
</div>
<div id="preamble">
<p class="man-template-autor ">Le Département fédéral de l’économie, de la formation et de la recherche (DEFR)</p>
<p class="man-template-verb ">arrête:</p>
</div>
<main id="maintext"><section id="lvl_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I">I</a>
</h1>
<div class="collapseable">
<p class="absatz ">L’ordonnance du DEFR du 20 mai 2019 sur le stockage obligatoire de médicaments<sup><a href="#fn-d8e21" id="fnbck-d8e21">1</a></sup> est modifiée comme suit:</p>
<p class="verweisartkursiv man-font-style-italic ">Art. 6, titre et al. 1</p>
<p class="absatz man-text-align-left "> Quantités à stocker d’analgésiques, de vaccins et de médicaments oncologiques à usage humain</p>
<p class="absatz "><sup>1</sup> La quantité totale de marchandises stockées listées dans l’annexe 1, ch. 4 à 5<i>a</i>, doit couvrir les besoins moyens de la population suisse pour la durée suivante:</p>
<dl>
<dt>a. </dt>
<dd>analgésiques: 3 mois;</dd>
<dt>b. </dt>
<dd>vaccins: 4 mois;</dd>
<dt>c. </dt>
<dd>médicaments oncologiques: 3 mois.</dd>
</dl>
<p class="verweisartkursiv man-font-style-italic ">Art. 6a, al. 1</p>
<p class="absatz "><sup>1</sup> La quantité totale de marchandises stockées listées dans l’annexe 1, ch. 5<i>b</i>, doit couvrir les besoins moyens de la population suisse durant 3 mois.</p>
<div class="footnotes"><p id="fn-d8e21"><sup><a href="#fnbck-d8e21">1</a></sup><sup></sup><sup> </sup><a href="https://fedlex.data.admin.ch/eli/cc/2019/351" target="_blank">RS <b>531.215.311</b></a></p></div>
</div></section><section id="lvl_II"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_II">II</a>
</h1>
<div class="collapseable"><p class="absatz ">Les annexes 1 et 2 sont modifiées conformément aux textes ci-joints.</p></div></section><section id="lvl_III"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_III">III</a>
</h1>
<div class="collapseable">
<p class="absatz ">La présente ordonnance entre en vigueur le 15 janvier 2024.</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				<td>
					
					<p class="unterschriftenfi1 ">24 novembre 2023</p>
				</td>
				<td>
					
					<p class="unterschriftenfi1 ">Département fédéral de l’économie, de la formation et de la recherche:</p>
					<p class="unterschriftenfi ">Guy Parmelin</p>
				</td>
			</tr>
		</table></div>
</div></section></main><div id="annex">
<section id="annex_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1">Annexe 1</a>
</h1>
<div class="collapseable">
<p class="titelanhtext ">(art. 1)</p>
<section id="annex_1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1">Marchandises visées à l’art. 1</a>
</h2>
<div class="collapseable">
<p class="verweisartkursiv man-font-style-italic ">Ch. 4 et 5a à 6</p>
<section id="annex_1/lvl_u1/lvl_4"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_4">4 Analgésiques à usage humain</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Code ATC</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Désignation de la marchandise</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Remarque</p>
				</th>
			</tr>
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-krpr ">N01AH06</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-krpr ">rémifentanil</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-krpr "></p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">morphine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">hydromorphone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxycodone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA51</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">morphine, associations</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA55</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxycodone avec naloxone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fentanyl</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AC52</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">méthadone, associations</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sauf psycholeptiques</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">buprénorphine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">morphine et antispasmodiques</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AG04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">hydromorphone et antispasmodiques</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acide acétylsalicylique y c. acétylsalicylate de lysine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N07BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">méthadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N07BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">lévométhadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_5_a"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_5_a">5<span class="man-font-weight-normal"><i>a</i></span> Médicaments oncologiques à usage humain</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Code ATC</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Désignation de la marchandise</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Remarque</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">melphalan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">méthotrexate</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tioguanine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cytarabine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">gemcitabine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">étoposide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">irinotécan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ancien code ATC L01XX19</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01DB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">doxorubicine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">non liposomale</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cisplatine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">carboplatine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxaliplatine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tamoxifène</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L03AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vaccin BCG</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_5_b"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_5_b">5<span class="man-font-weight-normal"><i>b</i></span> Autres médicaments à usage humain</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Code ATC</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Désignation de la marchandise</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Remarque</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">altéplase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dosage &gt; 2 mg</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">noradrénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dobutamine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">adrénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">auto-injecteurs</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">furosémide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">H01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ocytocine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M03AC09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">rocuronium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">propofol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08BA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">produits de contraste barytés</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08DA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">produits de contraste pour échographie</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_6"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_6">6 Anti-infectieux en médecine vétérinaire</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Code ATCvet*</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf "></p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Désignation de la marchandise</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QA07A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">néomycine</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AA10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">colistine</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AA51</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">néomycine, associations</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulfaguanidine</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AB20</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulfamides, associations</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QG51A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxytétracycline</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tétracycline</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">gentamicine</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">céfapirine</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tétracyclines</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01B</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">amphénicols</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01C</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">bêta-lactamines, pénicillines</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01D</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">autres bêta-lactamines</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01E</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulfamides et triméthoprime</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01F</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">macrolides et lincosamides</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01G</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">aminosides</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01M</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">quinolones</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01R</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">associations d’antibiotiques ou d’agents chimiothérapeutiques</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01X</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QJ01XQ01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tiamuline</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QJ01XQ02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">valnémuline</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ51C</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">bêta-lactamines, pénicillines à usage intramammaire</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ51D</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">autres bêta-lactamines à usage intramammaire</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ51R</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">associations d’antibiotiques à usage intramammaire</p>
				</td>
			</tr>
			<tr>
				
				<td colspan="3"><dl>
<dt>* </dt>
<dd>Les codes ATCvet (<i>Anatomical Therapeutic Chemical Classification system for </i><i>veterinary</i><i> medicinal products</i>) peuvent être consultés en anglais (version officielle) sur le site du Centre collaborateur de l’OMS pour la méthodologie sur les statistiques pharmaceutiques à l’adresse suivante: <a href="https://www.whocc.no/atcvet/atcvet_index/" target="_blank">
							www.whocc.no/ATCvet
						</a> &gt; ATCvet Index.</dd>
</dl></td>
			</tr>
		</table></div>
</div></section>
</div></section>
</div></section><section id="annex_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2">Annexe 2</a>
</h1>
<div class="collapseable">
<p class="titelanhtext ">(art. 2)</p>
<section id="annex_2/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1">Exemption de l’obligation de passer un contrat de stockage</a>
</h2>
<div class="collapseable">
<p class="verweisartkursiv man-font-style-italic ">Ch. 2</p>
<section id="annex_2/lvl_u1/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1/lvl_2">2 Anti-infectieux en médecine vétérinaire</a>
</h3>
<div class="collapseable"> <p class="absatz ">Est exemptée de l’obligation de passer un contrat de stockage toute personne qui met sur le marché, par année civile, des principes actifs en quantités inférieures à celles listées ci-dessous:</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf man-text-align-right ">Forme       </p>
					<p class="man-template-tab-kpf "><br>Famille de principe actif</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Traitement individuel</p>
					<p class="man-template-tab-kpf ">en kg</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Traitement collectif: (prémélange médicamenteux)</p>
					<p class="man-template-tab-kpf ">en kg</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">1000/2000 – bêta-lactamines</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">50</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">200</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         3000 – chloramphénicols</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">20</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">–</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         4000 – tétracyclines</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">20</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">200</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         5000 – macrolides</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">200</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">      9XXX – autres antibiotiques</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         9500 – aminosides</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">5</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         9900 – quinolones</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">50</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">       11000 – sulfamides / triméthoprime</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
		</table></div>
</div></section>
</div></section>
</div></section>
</div>
</div></body>
</html>
